nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Mood swings—Sorafenib—liver cancer	0.0264	0.0301	CcSEcCtD
Levorphanol—Estrone—ESR1—liver cancer	0.0221	0.179	CrCbGaD
Levorphanol—Renal failure—Sorafenib—liver cancer	0.0211	0.0241	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—liver cancer	0.021	0.024	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—liver cancer	0.0195	0.0222	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2E1—liver cancer	0.0186	0.151	CrCbGaD
Levorphanol—Flushing—Sorafenib—liver cancer	0.0179	0.0204	CcSEcCtD
Levorphanol—Estrone—CYP2E1—liver cancer	0.0179	0.145	CrCbGaD
Levorphanol—Estrone—CYP1A1—liver cancer	0.0176	0.143	CrCbGaD
Levorphanol—Arrhythmia—Sorafenib—liver cancer	0.0172	0.0197	CcSEcCtD
Levorphanol—Estradiol—ESR1—liver cancer	0.0167	0.135	CrCbGaD
Levorphanol—Muscle spasms—Sorafenib—liver cancer	0.0161	0.0184	CcSEcCtD
Levorphanol—Thinking abnormal—Epirubicin—liver cancer	0.0155	0.0177	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—liver cancer	0.0151	0.0172	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—liver cancer	0.0144	0.0164	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—liver cancer	0.0141	0.0161	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—liver cancer	0.014	0.016	CcSEcCtD
Levorphanol—Dry mouth—Sorafenib—liver cancer	0.014	0.016	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—liver cancer	0.014	0.016	CcSEcCtD
Levorphanol—Shock—Sorafenib—liver cancer	0.0135	0.0154	CcSEcCtD
Levorphanol—Estradiol—CYP1A1—liver cancer	0.0134	0.108	CrCbGaD
Levorphanol—Injection site reaction—Doxorubicin—liver cancer	0.0131	0.0149	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—liver cancer	0.013	0.0148	CcSEcCtD
Levorphanol—Coma—Epirubicin—liver cancer	0.013	0.0148	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—liver cancer	0.0124	0.0141	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—liver cancer	0.0123	0.0141	CcSEcCtD
Levorphanol—Dyspepsia—Sorafenib—liver cancer	0.0121	0.0138	CcSEcCtD
Levorphanol—Coma—Doxorubicin—liver cancer	0.012	0.0137	CcSEcCtD
Levorphanol—Constipation—Sorafenib—liver cancer	0.0117	0.0134	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—liver cancer	0.0115	0.0131	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—liver cancer	0.0114	0.013	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sorafenib—liver cancer	0.0112	0.0128	CcSEcCtD
Levorphanol—Urticaria—Sorafenib—liver cancer	0.0109	0.0124	CcSEcCtD
Levorphanol—Abdominal pain—Sorafenib—liver cancer	0.0108	0.0124	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—liver cancer	0.0105	0.012	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—liver cancer	0.0103	0.0118	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—liver cancer	0.0101	0.0116	CcSEcCtD
Levorphanol—Estrone—ALB—liver cancer	0.00982	0.0795	CrCbGaD
Levorphanol—Cardiac arrest—Epirubicin—liver cancer	0.0098	0.0112	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—liver cancer	0.00976	0.0111	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—liver cancer	0.00973	0.0111	CcSEcCtD
Levorphanol—Pruritus—Sorafenib—liver cancer	0.0097	0.0111	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—liver cancer	0.00954	0.0109	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—liver cancer	0.00939	0.0107	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—liver cancer	0.00907	0.0103	CcSEcCtD
Levorphanol—Dizziness—Sorafenib—liver cancer	0.00906	0.0103	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—liver cancer	0.00903	0.0103	CcSEcCtD
Levorphanol—Vomiting—Sorafenib—liver cancer	0.00872	0.00994	CcSEcCtD
Levorphanol—Rash—Sorafenib—liver cancer	0.00864	0.00986	CcSEcCtD
Levorphanol—Dermatitis—Sorafenib—liver cancer	0.00863	0.00985	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—liver cancer	0.00833	0.0095	CcSEcCtD
Levorphanol—Nausea—Sorafenib—liver cancer	0.00814	0.00929	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—liver cancer	0.00781	0.00891	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—liver cancer	0.00771	0.00879	CcSEcCtD
Levorphanol—Sweating—Epirubicin—liver cancer	0.00761	0.00869	CcSEcCtD
Levorphanol—Estradiol—ALB—liver cancer	0.00745	0.0603	CrCbGaD
Levorphanol—Bradycardia—Epirubicin—liver cancer	0.00726	0.00828	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—liver cancer	0.00722	0.00824	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—liver cancer	0.00705	0.00804	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—liver cancer	0.00687	0.00784	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—liver cancer	0.00672	0.00766	CcSEcCtD
Levorphanol—Flushing—Epirubicin—liver cancer	0.00662	0.00755	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—liver cancer	0.00637	0.00727	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—liver cancer	0.00636	0.00725	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—liver cancer	0.00612	0.00699	CcSEcCtD
Levorphanol—Tension—Epirubicin—liver cancer	0.00609	0.00695	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—liver cancer	0.00603	0.00688	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—liver cancer	0.00597	0.00681	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—liver cancer	0.00589	0.00672	CcSEcCtD
Levorphanol—Agitation—Epirubicin—liver cancer	0.0057	0.00651	CcSEcCtD
Levorphanol—Tension—Doxorubicin—liver cancer	0.00564	0.00643	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—liver cancer	0.00558	0.00636	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—liver cancer	0.00552	0.0063	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—liver cancer	0.00549	0.00626	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—liver cancer	0.00538	0.00614	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—liver cancer	0.00528	0.00602	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—liver cancer	0.00517	0.0059	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—liver cancer	0.00511	0.00583	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—liver cancer	0.00508	0.00579	CcSEcCtD
Levorphanol—Shock—Epirubicin—liver cancer	0.00498	0.00569	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—liver cancer	0.00498	0.00568	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—liver cancer	0.00494	0.00564	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—liver cancer	0.0049	0.00559	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—liver cancer	0.00478	0.00546	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—liver cancer	0.00473	0.0054	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—liver cancer	0.00473	0.00539	CcSEcCtD
Levorphanol—Shock—Doxorubicin—liver cancer	0.00461	0.00526	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—liver cancer	0.00458	0.00523	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—liver cancer	0.00457	0.00522	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—liver cancer	0.00453	0.00517	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—liver cancer	0.00446	0.00509	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—liver cancer	0.00438	0.005	CcSEcCtD
Levorphanol—Constipation—Epirubicin—liver cancer	0.00433	0.00494	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—liver cancer	0.00424	0.00484	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—liver cancer	0.00417	0.00476	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—liver cancer	0.00414	0.00473	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—liver cancer	0.00413	0.00471	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—liver cancer	0.00402	0.00459	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—liver cancer	0.00401	0.00457	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—liver cancer	0.004	0.00457	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—liver cancer	0.00386	0.00441	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—liver cancer	0.00383	0.00437	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—liver cancer	0.00372	0.00425	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—liver cancer	0.00371	0.00423	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—liver cancer	0.00358	0.00409	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—liver cancer	0.00335	0.00382	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—liver cancer	0.00332	0.00378	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—liver cancer	0.00322	0.00368	CcSEcCtD
Levorphanol—Rash—Epirubicin—liver cancer	0.00319	0.00364	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—liver cancer	0.00319	0.00364	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—liver cancer	0.0031	0.00354	CcSEcCtD
Levorphanol—Nausea—Epirubicin—liver cancer	0.00301	0.00343	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—liver cancer	0.00298	0.0034	CcSEcCtD
Levorphanol—Rash—Doxorubicin—liver cancer	0.00296	0.00337	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—liver cancer	0.00295	0.00337	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—liver cancer	0.00278	0.00318	CcSEcCtD
